We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Recommends Up-Scheduling Hydrocodone Combination Products to Thwart Misuse, Abuse
FDA Recommends Up-Scheduling Hydrocodone Combination Products to Thwart Misuse, Abuse
October 25, 2013
In a long-awaited decision, CDER Director Janet Woodcock Oct. 24 said the FDA will soon recommend to HHS that the prescription painkiller hydrocodone be reclassified to a more restrictive schedule — Schedule II.